Jemima Merilan
About Jemima Merilan
Jemima Merilan is a Manager of QC Incoming CAR-T at Bristol Myers Squibb in Summit, New Jersey, with extensive experience in quality control and biochemistry.
Company
Jemima Merilan is currently employed at Bristol Myers Squibb, located in Summit, New Jersey, United States. She holds the position of Manager, QC Incoming CAR-T, a role focused on quality control in the cutting-edge field of CAR-T cell therapy.
Title
Jemima Merilan serves as the Manager, QC Incoming CAR-T at Bristol Myers Squibb. This position involves overseeing quality control processes for CAR-T cell therapy, which is a revolutionary cancer treatment technology.
Education and Expertise
Jemima Merilan obtained her Master’s degree in Biotechnology from Kean University. She also has a Bachelor of Applied Science (BASc) in Chemistry with a concentration in Biochemistry from Bloomfield College, where she studied from 2009 to 2013. Her educational background is complemented by extensive experience in quality control and scientific research.
Professional Experience
Jemima’s career includes various roles in scientific and quality control positions. At Bristol Myers Squibb, she served as QC Incoming Team Lead in 2022 and as QC Associate Scientist - CAR-T from 2019 to 2022. Previously, she worked at Amneal Pharmaceuticals as Scientist II in 2019 and Scientist I from 2018 to 2019. Her early career includes roles such as a Biophysical Technician/Project Manager at Clinical Research Laboratories, LLC, a Substitute Teacher at Linden Board Of Education, and a Biochemist at DPT Laboratories. Jemima also worked as a GC/MS Lab Analyst I at SGS Accutest and as a Supervisor at Payless ShoeSource for six years.
CAR-T Quality Control at Bristol Myers Squibb
Jemima Merilan has significantly contributed to the field of CAR-T cell therapy quality control during her tenure at Bristol Myers Squibb. Her work in QC Incoming CAR-T involves ensuring the integrity and safety of these innovative treatments, which are crucial for advancing cancer therapy.